Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
Titel:
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
Auteur:
McGowan, Barbara M Bruun, Jens M Capehorn, Matt Pedersen, Sue D Pietiläinen, Kirsi H Muniraju, Hanna Angelene Kudiyanur Quiroga, Maria Varbo, Anette Lau, David C W